Surgery Partners (SGRY) to Release Quarterly Earnings on Monday

Surgery Partners (NASDAQ:SGRY) is expected to announce its Q4 2025 results before the market opens on Monday, March 2nd. Analysts expect Surgery Partners to post earnings of $0.31 per share and revenue of $866.5440 million for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, March 6, 2026 at 12:30 PM ET.

Surgery Partners Stock Up 1.2%

SGRY stock opened at $15.54 on Monday. The company has a current ratio of 1.88, a quick ratio of 1.72 and a debt-to-equity ratio of 1.10. The firm has a 50 day simple moving average of $15.37 and a 200-day simple moving average of $18.65. The company has a market capitalization of $2.01 billion, a P/E ratio of -11.43 and a beta of 1.97. Surgery Partners has a twelve month low of $13.14 and a twelve month high of $25.83.

Wall Street Analysts Forecast Growth

SGRY has been the topic of a number of recent research reports. UBS Group cut their target price on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, November 13th. Mizuho cut their price target on Surgery Partners from $22.00 to $19.00 and set an “outperform” rating on the stock in a report on Thursday, December 18th. Royal Bank Of Canada reduced their price objective on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. Barclays lowered their price objective on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating for the company in a research note on Friday, November 21st. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Surgery Partners in a research note on Monday, December 29th. Seven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $27.11.

Institutional Trading of Surgery Partners

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd lifted its stake in Surgery Partners by 45,640.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after buying an additional 2,282 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Surgery Partners by 128.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 2,702 shares of the company’s stock valued at $58,000 after acquiring an additional 1,519 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in Surgery Partners in the 3rd quarter worth approximately $121,000. Tower Research Capital LLC TRC grew its position in Surgery Partners by 68.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,313 shares of the company’s stock worth $207,000 after purchasing an additional 3,794 shares in the last quarter. Finally, Prudential Financial Inc. acquired a new stake in Surgery Partners during the 2nd quarter valued at $219,000.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.